Summary
This Cochrane systematic review synthesised 101 randomised controlled trials (50,325 participants) and 13 additional studies to evaluate the effectiveness and safety of daily oral iron supplementation in children and adolescents aged 0–19 years. Daily iron supplementation alone produced little to no difference in height-for-age z-score or weight-for-height z-score, and had minimal effect on common morbidities including cough and fever, based on high-certainty evidence. The review contributes to global efforts to reduce childhood anaemia by clarifying both the benefits and potential harms of iron supplementation strategies.
Regional applicability
The findings are globally applicable and directly relevant to United Kingdom clinical practice and public health policy, particularly for assessment of iron supplementation programmes in vulnerable paediatric populations. The high-certainty evidence on growth outcomes and morbidity informs UK guidance on iron supplementation in infants, children, and adolescents, though UK-specific prevalence of iron deficiency differs from global patterns.
Key measures
Anaemia status; iron deficiency; iron-deficiency anaemia; height/length-for-age z-score (H(L)AZ); weight-for-height/length z-score (W(H(L)Z); morbidity (cough, fever, respiratory illness, diarrhoea); adverse events (vomiting, diarrhoea, constipation, stool discolouration).
Outcomes reported
The systematic review assessed the effects of daily oral iron supplementation (alone or combined with folic acid or other vitamins/minerals) on anaemia, iron deficiency, iron-deficiency anaemia, growth, morbidity (respiratory illness, diarrhoea, fever), and adverse events (vomiting, diarrhoea, constipation, stool discolouration) in children and adolescents aged 0–19 years.
Topic tags
Dig deeper with Pulse AI.
Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.